• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Phio Pharmaceuticals Corp. - Common Stock (NQ:PHIO)

    1.140 -0.020 (-1.72%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,347,548
    Open 1.190
    Bid (Size) 1.140 (3,000)
    Ask (Size) 1.160 (500)
    Prev. Close 1.160
    Today's Range 1.070 - 1.260
    52wk Range 0.8127 - 4.190
    Shares Outstanding 5,726,750
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Phio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894
    Leadership Enhancements Position Company for Upcoming Regulatory Engagement and Clinical MilestonesNew Appointments Reinforce Operational Readiness Across Finance, Regulatory Affairs and... 
    Via Newsfile
    Topics Initial Public Offering
    Here are the top movers in Wednesday's session. ↗
    Via Chartmill

    Performance

    YTD
    +4.6%
    +4.6%
    1 Month
    +5.6%
    +5.6%
    3 Month
    -4.2%
    -4.2%
    6 Month
    -44.9%
    -44.9%
    1 Year
    -34.5%
    -34.5%

    More News

    Read More
    Top movers in Wednesday's session ↗
    Via Chartmill
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    These stocks are making the most noise in today's session. ↗
    Via Chartmill
    Here are the top movers in Tuesday's session. ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    Top movers in Tuesday's pre-market session ↗
    Via Chartmill
    News headline image
    Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762
    Via Newsfile
    Topics Supply Chain
    News headline image
    Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
    Via Newsfile
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program
    Via Newsfile
    News headline image
    Aprea Therapeutics (Nasdaq: APRE) Transforms Cutting-Edge Science into Next-Generation Cancer Therapies – More Stocks Inside
    Via AB Newswire
    Topics Artificial Intelligence
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?
    Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.
    What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?
    Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?
    The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market
    What is the current price of Phio Pharmaceuticals Corp. - Common Stock?
    The current price of Phio Pharmaceuticals Corp. - Common Stock is 1.140
    When was Phio Pharmaceuticals Corp. - Common Stock last traded?
    The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 02/19/26 04:00 PM ET
    What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?
    The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 6.53M
    How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?
    Phio Pharmaceuticals Corp. - Common Stock has 7M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.